Get Started

ROIV

NASD Roivant Sciences Ltd.
Oct 23, 2026 · 10:16 AM ET DELAYED Market Open

$36.79 ↓ -0.66 (-1.76%) Trading Down from the previous close of $37.45, $0.63 below the day’s high of $37.42

YTD change
+69.54%
vs 20-day SMA
+4.25%
vs 200-day SMA
+18.39%

Price ranges

Previous day
$36.68 $38.49
open $36.68 close $37.45
+$0.77 (+2.10%)
Today
$36.54 $37.42
open $37.23 now $36.79
-$0.44 (-1.18%)
Past week
$33.23 $38.49
from $34.04 now $36.79
+$2.75 (+8.08%)
Past month
$33.00 $38.49
from $36.13 now $36.79
+$0.66 (+1.83%)
This year
$20.78 $42.50
from $21.70 now $36.79
+$15.09 (+69.54%)

Price & Performance

+9.31 (+33.08%) / 6M

$26.26$31.83$37.39$42.96Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 13.4% away from all-time highs of $42.50
  • ROIV is up 70% since the beginning of the year
  • ROIV is up 103% over the past 12 months
  • ROIV is up 2% over the past 1 month
  • 7% of all ROIV investors are betting against ROIV

ROIV reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +106.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.33472
Earnings momentum +8.8% Quarterly EPS growth
Quarterly change +8.8%

Valuation

P/E ratio N/A
Enterprise value $23.9B
Beta 0.66

Balance sheet & scale

IncomeN/A
Revenue$7.5M
Cash$3.8B
Debt$107.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $26.6B

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%
MEDP Medpace Holdings, Inc. $653.96 -1.29%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.